Benjamin Johnson
Overview
Explore the profile of Benjamin Johnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
1326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McKeeman J, Johnson B, Rivera J
Cureus
. 2025 Mar;
17(2):e78580.
PMID: 40062130
Athletic pubalgia is a relatively uncommon injury that is not fully understood. There are few high-level studies comparing treatments of athletic pubalgia, and this investigation seeks to utilize original articles...
2.
Johnson B, Sun T, Wu L, Seal S, Stjepanovic D, Chan G, et al.
J Atten Disord
. 2025 Feb;
:10870547251318834.
PMID: 39963814
Background: TikTok has become a significant influence on public health perceptions, especially regarding ADHD. With its expansive reach among younger demographics, TikTok content has the potential to shape public understanding...
3.
Chou J, Nickel I, Bugaev N, Hojman H, Johnson B, Kim W, et al.
Curr Probl Surg
. 2024 Oct;
61(11):101590.
PMID: 39477677
No abstract available.
4.
Brenner M, Johnson B, Shea K, Ganley T, Wilson P, Ellis H
J Pediatr Orthop
. 2024 Oct;
45(2):57-63.
PMID: 39466263
Background: The Delphi technique is a structured, iterative group survey method utilized to reach a consensus among experts in a field regarding topics with evidence-based equipoise. Currently, there are few...
5.
Johnson B, Stjepanovic D, Leung J, Chan G
J Atten Disord
. 2024 Oct;
29(2):120-127.
PMID: 39377515
Background: The shortage of prescription stimulants is an ongoing issue that is impacting the ability of individuals with ADHD to access their medication. Amidst concerns that this shortage may have...
6.
Blyth S, Cruz Bosch C, Raffoul J, Chesley J, Johnson B, Borodge D, et al.
Schizophr Bull
. 2024 Sep;
51(2):392-400.
PMID: 39278637
Background And Hypothesis: Current treatments for schizophrenia are only partially effective, and there are no medications for negative symptoms or cognitive impairment. Neuromodulation, such as repetitive transcranial magnetic stimulation (rTMS),...
7.
Yuan X, Su Y, Johnson B, Kirchner M, Zhang X, Xu S, et al.
J Am Chem Soc
. 2024 Sep;
146(37):25600-25613.
PMID: 39231532
Despite the extensive use of next-generation sequencing (NGS) of RNA, simultaneous direct sequencing and quantitative mapping of multiple RNA nucleotide modifications remains challenging. Mass spectrometry (MS)-based sequencing can directly sequence...
8.
Smack C, Johnson B, Nyalwidhe J, John Semmes O, Yang L
Adv Cancer Res
. 2024 Jul;
161:119-190.
PMID: 39032949
Prostate cancer is a significant health problem in the United States. It is remarkably heterogenous, ranging from slow growing disease amenable to active surveillance to highly aggressive forms requiring active...
9.
Kuhn B, Cannella N, Chitre A, Nguyen K, Cohen K, Chen D, et al.
bioRxiv
. 2024 May;
PMID: 38712202
The increased prevalence of opioid use disorder (OUD) makes it imperative to disentangle the biological mechanisms contributing to individual differences in OUD vulnerability. OUD shows strong heritability, however genetic variants...
10.
Zimmerman D, Johnson B, Kearns A, Metro H, Robb A, Nemecek B, et al.
Am J Emerg Med
. 2023 Dec;
77:154-157.
PMID: 38150985
Objective: Buprenorphine is an effective treatment for opioid use disorder (OUD). Patients in the emergency department (ED) can be initiated or continued on buprenorphine as a bridge to follow-up in...